Proactive Investors - Run By Investors For Investors

BioXcel Therapeutics using AI to find new drugs for immuno-oncology

BioXcel Therapeutics Inc (NASDAQ:BTAI) CEO Vimal Mehta sat down with Proactive Investors at the BIO CEO and Investor Conference in New York.

BioXcel is a clinical stage biopharmaceutical company that utilizes artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology.

 
View full BTAI profile View Profile

BioXcel Therapeutics Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use